26. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodies
- PMID: 12592317
- DOI: 10.1067/mai.2003.146
26. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodies
Abstract
The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune modulation and immunotherapy. A number of soluble growth and activation factors are released from various cell populations involved in the immune response. They play vital roles in the initiation, propagation, and regulation of immunologic responses. Pharmacologic immunomodulators include suppressive and stimulatory agents. Immunosuppressive therapies include antimetabolites, cytotoxic drugs, radiation, adrenocortical glucocorticosteroids, immunophilins, and therapeutic antibodies. The field of clinical immunostimulation is emerging as an important therapeutic modality for a number of immunodeficiency diseases, chronic viral infections, and cancer. These compounds will be discussed in terms of general principles, molecular targets, major indications, and adverse effects.
Similar articles
-
[Immunotherapy in non-allergic diseases].Allergol Immunopathol (Madr). 2000 May-Jun;28(3):107-9. Allergol Immunopathol (Madr). 2000. PMID: 10867379 Review. Spanish.
-
Cytokines and their antagonists as therapeutic agents.Curr Med Chem. 2002 Dec;9(24):2201-7. doi: 10.2174/0929867023368656. Curr Med Chem. 2002. PMID: 12470242 Review.
-
Immunomodulating drugs: major advances in research and development.Ann N Y Acad Sci. 1993 Jun 23;685:1-10. doi: 10.1111/j.1749-6632.1993.tb35844.x. Ann N Y Acad Sci. 1993. PMID: 8363213 Review. No abstract available.
-
Novel immunotherapies for psoriasis.Trends Immunol. 2002 Jan;23(1):47-53. doi: 10.1016/s1471-4906(01)02119-6. Trends Immunol. 2002. PMID: 11801454 Review.
-
Managing HIV. Part 4: Primary therapy. 4.2 Immune-based therapy for HIV infection.Med J Aust. 1996 Mar 4;164(5):297-300. Med J Aust. 1996. PMID: 8628166 Review.
Cited by
-
Prevention of Prostate Tumor Development by Stimulation of Antitumor Immunity Using a Standardized Herbal Extract (Deep Immune®) in TRAMP Mice.Evid Based Complement Alternat Med. 2018 May 14;2018:9707543. doi: 10.1155/2018/9707543. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 29861778 Free PMC article.
-
Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.Tissue Barriers. 2020;8(1):1695476. doi: 10.1080/21688370.2019.1695476. Epub 2019 Nov 28. Tissue Barriers. 2020. PMID: 31775577 Free PMC article.
-
Developing Phytocompounds from Medicinal Plants as Immunomodulators.Adv Bot Res. 2012;62:197-272. doi: 10.1016/B978-0-12-394591-4.00004-0. Epub 2012 Jun 19. Adv Bot Res. 2012. PMID: 32300254 Free PMC article.
-
Treatment of patients with immunodeficiency: Medication, gene therapy, and transplantation.J Pediatr (Rio J). 2021 Mar-Apr;97 Suppl 1(Suppl 1):S17-S23. doi: 10.1016/j.jped.2020.10.005. Epub 2020 Nov 9. J Pediatr (Rio J). 2021. PMID: 33181112 Free PMC article. Review.
-
The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study.PLoS One. 2014 Sep 30;9(9):e108794. doi: 10.1371/journal.pone.0108794. eCollection 2014. PLoS One. 2014. PMID: 25268806 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources